| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |